| Revenue | SEK 2,1M | +6% |
| EBITDA | SEK 1,9M | +4% |
| Net profit | SEK -96K | +81% |
| Total assets | SEK 16M | +1% |
| Equity | SEK 101K | +31% |
| Employees | 0 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 769 | 1 773 | 1 822 | 2 016 | 2 146 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 461 | 1 239 | 1 532 | 1 783 | 1 858 |
| Depreciation & amort. | −928 | −928 | −930 | −930 | −402 |
| EBIT | 533 | 311 | 602 | 853 | 1 456 |
| Net financials | −116 | −102 | −102 | −117 | −61 |
| Profit before tax | −647 | −634 | −613 | −649 | −121 |
| Tax | 134 | 134 | 126 | 134 | 25 |
| Net profit | −513 | −500 | −487 | −515 | −96 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 035 | 16 861 | 17 696 | 15 793 | 15 974 |
| Equity | 159 | 259 | 102 | 77 | 101 |
| Long-term debt | 14 850 | 14 850 | 16 502 | 14 968 | 15 051 |
| Short-term debt | 1 026 | 1 752 | 1 092 | 710 | 791 |
| Total debt | 15 876 | 16 602 | 17 594 | 15 678 | 15 842 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EJ Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
EO Chief Auditor | Chief Auditor | 2020 – 2022 |
SJ Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
| Person | Role here | Other companies |
|---|---|---|
| Erik Oskar Wall | Chief Auditor | 0 companies |
| Erik John-David Larsson | Chief Auditor | 0 companies |
| Sten Johan Pharmanson | Chief Auditor | 0 companies |
| Per-Henrik Roger Karlsson | Deputy Board Member | 0 companies |
| Mikael Ulf Robert Nicander | Board of Directors | 0 companies |
| Jan Erik Alexander Ranje | Board of Directors | 0 companies |